This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Massachusetts Institute of Technology, The General Hospital Corporation. Active years: 2015-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2015-2021
Title: Innovations of Inventor Ling Pan
Introduction
Ling Pan is a notable inventor based in Charlestown, MA (US). He has made significant contributions to the field of neurology through his innovative patents. With a total of 3 patents, his work focuses on the treatment and prevention of various neurological disorders.
Latest Patents
Ling Pan's latest patents include "Activators of class I histone deacetylases (HDACs) and uses thereof." This invention provides compounds of Formulae (A), (B), (C), and (D), along with their pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrugs. The invention outlines methods for using these compounds to treat or prevent neurological disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, ALS, and various other conditions. The methods involve administering a therapeutically effective amount of specific compounds to subjects in need of treatment.
Career Highlights
Ling Pan has worked with prestigious institutions, including the Massachusetts Institute of Technology and The General Hospital Corporation. His experience in these organizations has contributed to his expertise in the field of neurological research and innovation.
Collaborations
Some of his notable coworkers include Li-Huei Tsai and Stephen J Haggarty. Their collaboration has likely enhanced the impact of his research and inventions.
Conclusion
Ling Pan's contributions to the field of neurology through his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to significantly improve the treatment of various neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile